Showing results (631-640 of 686) with videos related to
Sort By:
Pageof 69
Diabetes, Obesity & Metabolism|July 9, 2019
Long-term efficacy and safety of combined insulin and glucagon-like peptide-1 therapy: Evidence from the LEADER trialCees J Tack, Stephan Jacob, Cyrus Desouza, et al.Transplantation Proceedings|August 16, 2006
Selection criteria and outcome of patients referred to intestinal transplantation: an European center experienceJ Pirenne, I Hoffman, M Miserez, et al.Diabetes, Obesity & Metabolism|May 22, 2024
Association between recent exposure to continuous glucose monitoring-recorded hypoglycaemia and counterregulatory and symptom responses to subsequent controlled hypoglycaemia in people with type 1 diabetesCecilie H Svensson, Therese W Fabricius, Clementine E M Verhulst, et al.Bone Marrow Transplantation|September 7, 2010
Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapyG J Tack, M J Wondergem, A Al-Toma, et al.The Journal of Biological Chemistry|July 15, 2018
Interleukin-37 treatment of mice with metabolic syndrome improves insulin sensitivity and reduces pro-inflammatory cytokine production in adipose tissueDov B Ballak, Suzhao Li, Giulio Cavalli, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2001
Randomized, double-blind, multicenter trial comparing clinafloxacin with imipenem as empirical monotherapy for febrile granulocytopenic patientsD J Winston, H M Lazarus, R A Beveridge, et al.The New England Journal of Medicine|June 12, 2019
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 DiabetesMansoor Husain, Andreas L Birkenfeld, Morten Donsmark, et al.Acta Gastro-Enterologica Belgica|June 12, 2025
Recommendations for the diagnosis and management of patients with chronic idiopathic diarrhea: Belgian multidisciplinary expert discussion based on a modified Delphi methodT Vanuytsel, J Arts, V Casneuf, et al.Molecular Immunology|February 28, 2012
Origin and immunophenotype of aberrant IEL in RCDII patientsGreetje J Tack, Roy L J van Wanrooij, Anton W Langerak, et al.Diabetes, Obesity & Metabolism|January 19, 2021
Limited impact of impaired awareness of hypoglycaemia and severe hypoglycaemia on the inflammatory profile of people with type 1 diabetesNamam Ali, Anna W M Janssen, Martin Jaeger, et al.Pageof 69